1. Home
  2. AIN vs NVAX Comparison

AIN vs NVAX Comparison

Compare AIN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIN
  • NVAX
  • Stock Information
  • Founded
  • AIN 1895
  • NVAX 1987
  • Country
  • AIN United States
  • NVAX United States
  • Employees
  • AIN N/A
  • NVAX N/A
  • Industry
  • AIN Textiles
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AIN Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • AIN Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • AIN 1.7B
  • NVAX 1.4B
  • IPO Year
  • AIN 1987
  • NVAX 1995
  • Fundamental
  • Price
  • AIN $47.82
  • NVAX $7.41
  • Analyst Decision
  • AIN Hold
  • NVAX Hold
  • Analyst Count
  • AIN 4
  • NVAX 7
  • Target Price
  • AIN $64.25
  • NVAX $10.71
  • AVG Volume (30 Days)
  • AIN 365.9K
  • NVAX 4.3M
  • Earning Date
  • AIN 11-05-2025
  • NVAX 11-06-2025
  • Dividend Yield
  • AIN 2.24%
  • NVAX N/A
  • EPS Growth
  • AIN N/A
  • NVAX N/A
  • EPS
  • AIN N/A
  • NVAX 2.07
  • Revenue
  • AIN $1,148,512,000.00
  • NVAX $1,064,651,000.00
  • Revenue This Year
  • AIN N/A
  • NVAX $59.49
  • Revenue Next Year
  • AIN $3.93
  • NVAX N/A
  • P/E Ratio
  • AIN N/A
  • NVAX $3.59
  • Revenue Growth
  • AIN N/A
  • NVAX 20.27
  • 52 Week Low
  • AIN $47.65
  • NVAX $5.01
  • 52 Week High
  • AIN $88.13
  • NVAX $11.55
  • Technical
  • Relative Strength Index (RSI)
  • AIN 23.78
  • NVAX 35.58
  • Support Level
  • AIN $51.15
  • NVAX $7.50
  • Resistance Level
  • AIN $56.91
  • NVAX $7.90
  • Average True Range (ATR)
  • AIN 2.48
  • NVAX 0.34
  • MACD
  • AIN -0.86
  • NVAX -0.12
  • Stochastic Oscillator
  • AIN 1.14
  • NVAX 8.02

About AIN Albany International Corporation

Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: